Taysha Gene Therapies

Last updated: October 31, 2025
RA Session II, president, CEO and founder
RA Session II, president, CEO and founder
Country: USA | Funding: $743M (+)

Website: https://tayshagtx.com/

Taysha Gene Therapies is a developer of treatments to eradicate severe & life-threatening monogenic diseases of the central nervous system.




Competitors